SciVac Ltd.

SciVac Ltd. (formerly SciGen IL) is a high growth biopharmaceutical company that develops, produces, and markets life-saving recombinant human health care biotechnology products. SciVac's focus is in the areas of endocrinology, gastroenterology, and immunology. Sci-B-Vac®, our flagship product, is the only commercially available 3rd generation Hepatitis B vaccine. Clinical trials have proven the advantages of Sci-B-Vac® over competing vaccines in combating the Hepatitis B virus (HBV). SciVac Ltd. offers contract development and manufacturing services to the Life-science and Biotech markets. The company has the facilities and expertise to co-develop therapeutic proteins through upstream and downstream development, and offers effective, robust and swift technical transfers and modern facilities with best in class systems. SciVac also collaborates with strategic partners and institutions in order to continuously fill & improve its pipeline SciVac IL has a full range of analytical development capabilities in compliance with Pharmacopeia (EP/USP) and ICH guidelines to test raw materials and in-process control and release. Moreover, SciVac has a system of Quality Assurance (QA) that provides support at all stages of production in accordance with regulatory procedures.